A look at what's coming to Contemporary OB/GYN® this week.
The drug is used to treat bacterial vaginosis and is a generic version of Bausch Health US LLC’s MetroGel-Vaginal.
Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
February is American Heart Month. Each week, explore the facts, statistics, and resources available for women's heart health.
Coming soon
Risk assessment, lifestyle counseling, adverse effects, and medication management.
Coming soon
Friday marks World Cancer Day, an international awareness campaign led by the Union for International Cancer Control (IUCC). This year's theme is #CloseTheCareGap. Check back for toolkits, infographics, posters and more.
Coming soon
This week marks the beginning of the Society for Maternal-Fetal Medicine's 2022 Annual Meeting. Join us for the best of this year's virtual presentations, panel discussions, roundtables, and more.
Coming soon
Study: Plant-based diets lower hypertensive disorders of pregnancy risk
March 28th 2024A recent study suggests that adherence to plant-based diets significantly decreases the risk of developing hypertensive disorders of pregnancy, shedding light on dietary interventions for maternal health.
Read More
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More